undamentalytics Newsletter

Accendra Health Inc income statement

In fiscal 2025, Accendra Health Inc reported revenue of $2.76bn, up 3.1% on the year before, operating income of $27.5m (a 1.0% margin) and net income of −$1.10bn, or −$14.31 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Accendra Health Inc: income statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue8,0388,1248,6288,8689,0729,4409,7739,7239,3189,4189,2118,4809,7859,9552,5532,6802,7622,647
Cost of revenue———————8,5368,1468,3488,0827,1998,2728,1291,3361,4001,4731,460
Gross profit8148088589251,1171,1701,2151,1871,1721,0711,1281,2811,5131,8262,1252,2191,2891,187
Research and development————————————12121313——
Selling, general and administrative5925646116838649849949701,0179531,0231,0411,0771,5551,0021,0821,0681,036
Operating income20119620419719816020020089−35273204368143133−2182729
Interest expense13141413131827273271988348129117108107124
Income before tax18818219018318512617317357−427−291102771115−330−102−115
Income tax7171757474607064−15−32−62255−116211−5
Net income1051111151091116710310973−437−623022222−41−363−1,101−302
Diluted EPS$1.67$1.75$1.81$1.72$1.76$1.06$1.65$1.76$1.20−$7.28−$1.03$0.47$2.94$0.29−$0.53−$4.73−$14.31−$3.94
Diluted shares (average)62m63m63m63m63m62m62m61m60m60m61m64m75m76m77m77m77m77m
EBITDA227225238236249223266255149−250190297459372344−36242285

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ACH vs YIACH vs HSICACH vs COSM

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from Accendra Health Inc's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Accendra Health Inc.